Zimmer Biomet Holdings (ZBH) Income towards Parent Company (2009 - 2026)
Zimmer Biomet Holdings (ZBH) posted quarterly Income towards Parent Company of $238.3 million for Q1 2026, up 30.58% year-over-year from $182.5 million in Q1 2025, and up 129.05% quarter-over-quarter from -$820.4 million in Q4 2025.
Zimmer Biomet Holdings (ZBH) Income towards Parent Company (2009 - 2026) Analysis & Trends
Zimmer Biomet Holdings' Income towards Parent Company history runs 18 years deep, the most recent figure standing at $238.3 million for Q1 2026.
- In Q1 2026, Income towards Parent Company rose 30.58% year-over-year to $238.3 million; the TTM figure through Mar 2026 stood at -$197.5 million (down 251.81% YoY), while the FY2025 annual figure was -$253.2 million, changed N/A from the prior year.
- Income towards Parent Company for Q1 2026 stood at $238.3 million, up from -$820.4 million in the prior quarter.
- The five-year high for Income towards Parent Company was $419.7 million in Q4 2023, with the low at -$820.4 million in Q4 2025.
- The 5-year median for Income towards Parent Company is $196.2 million (2023), against an average of $76.6 million.
- The sharpest annual moves came in 2022 and 2023: Income towards Parent Company sank 1351.06% in 2022, then jumped 495.75% in 2023.
- Zimmer Biomet Holdings' Income towards Parent Company stood at -$58.8 million in 2022, then jumped by 813.78% to $419.7 million in 2023, then sank by 229.78% to -$544.7 million in 2024, then tumbled by 50.62% to -$820.4 million in 2025, then jumped by 129.05% to $238.3 million in 2026.
- Business Quant data shows ZBH's Income towards Parent Company at $238.3 million in Q1 2026, -$820.4 million in Q4 2025, and $231.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn |
| 2 | Stryker | 129.71 Bn | 126.23 Bn | 4.50 Bn |
| 3 | Medtronic | 120.07 Bn | 110.85 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.03 Bn | 31.92 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.51 Bn | 23.19 Bn | 4.55 Bn |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.37 Bn | 18.96 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 199.60 Mn |
| Mar 31, 2026 | 238.30 Mn |
| Dec 31, 2025 | -820.40 Mn |
| Sep 30, 2025 | 231.20 Mn |
| Jun 30, 2025 | 153.40 Mn |
| Mar 31, 2025 | 182.50 Mn |
| Dec 31, 2024 | -544.70 Mn |
| Sep 30, 2024 | 249.20 Mn |
| Jun 30, 2024 | 243.10 Mn |
| Mar 31, 2024 | 172.80 Mn |
| Dec 31, 2023 | 419.70 Mn |
| Sep 30, 2023 | 162.80 Mn |
| Jun 30, 2023 | 209.90 Mn |
| Mar 31, 2023 | 232.70 Mn |
| Mar 31, 2022 | -58.80 Mn |
| Dec 31, 2021 | -29.20 Mn |
| Sep 30, 2021 | -16.60 Mn |
| Jun 30, 2021 | -2.30 Mn |
| Mar 31, 2021 | 4.70 Mn |
| Dec 31, 2020 | 401.30 Mn |